Oximal 7.5 Mg - 30 Tabs

Product Name

• Oximal 7.5 Mg, Analgesic, Antipyretic & Anti-Inflammatory - 30 Tablets

Scientific Name

• Meloxicam 7.5 Mg Tablets

Category Of Oximal 7.5 Mg Tablets

• Analgesic, Antipyretic & Anti-Inflammatory Drugs

Mechanism Of Action Of Meloxicam

• The main mechanism of action of NSAIDs is the inhibition of the enzyme cyclooxygenase (COX).
• Cyclooxygenase is required to convert arachidonic acid into thromboxanes, prostaglandins, and prostacyclins. The body releases these substances in response to illness and injury.
• Meloxicam reduces pain, fever, swelling, and inflammation

Therapeutic Indications Of Oximal 7.5 Mg Tablets

• Short term symptomatic treatment of acute mild to moderate pain in adults
• Symptomatic treatment of pain and inflammation in osteoarthritis in adults
• Symptomatic treatment of pain and inflammation in rheumatoid arthritis in adults

Method Of Administration Of Oximal 7.5 Mg Tablets

• Use the lowest effective dose for the shortest duration consistent with
• individual treatment goals for the individual patient.
• Osteoarthritis and Rheumatoid Arthritis:

1. Starting dose: 7.5 mg once daily
2. The dose may be increased to 15 mg once daily

• Juvenile Rheumatoid Arthritis (JRA): 0.125 mg/kg once daily up to a maximum of 7.5 mg. JRA dosing using the oral suspension should be individualized based on the weight of the child.
• Doses may be changed in special conditions so always follow your doctor's or pharmacist's instructions.
• If you take more than you should, talk to a doctor or go to the hospital straight away.
• If you forget to take a dose, take it as soon as you remember it unless it is nearly time for your next dose.
• Do not take a double dose (two doses at the same time) to make up for the forgotten dose.

Undesirable Side Effects Of Oximal 7.5 Mg Tablets

• Most common (≥5% and greater than placebo) adverse events in adults are diarrhea, upper respiratory tract infections, dyspepsia, and influenza like symptoms
• Adverse events observed in pediatric studies were similar in nature to the adult clinical trial experience

Pregnancy & Breastfeeding Precautions While Taking Oximal 7.5 Mg Tablets

• If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Non-Pharmacological Treatments & Advice To Reduce Pain

• Massage: A lot of people find relief from gentle massage, and some hospice agencies have volunteers who are trained in massage therapy.
• Physical therapy
• Gel packs.

Warnings & Special Precautions while Taking Oximal 7.5 Mg Tablets

• Concomitant use of this drug and warfarin may result in an increased risk of bleeding complications
• Concomitant use of this drug and aspirin is not generally recommended because of the potential of increased adverse effects including increased GI bleeding
• Concomitant use with this drug increases lithium plasma levels
• Concomitant use with NSAIDs may reduce the antihypertensive effect of ACE-inhibitors
• Due to the presence of sorbitol in this drug oral suspension, there may be a risk of intestinal necrosis (possibly fatal) when the oral suspension is administered concomitantly with sodium polystyrene sulfonate
• Serious gastrointestinal (GI) adverse events can be fatal. The risk is greater in patients with a prior history of ulcer disease or GI bleeding, and in patients at higher risk for GI events, especially the elderly.
• Elevated liver enzymes, and rarely, severe hepatic reactions. Discontinue use immediately if abnormal liver enzymes persist or worsen.
• New onset or worsening of hypertension. Blood pressure should be monitored closely during the treatment.
• Fluid retention and edema. Should be used with caution in patients with fluid retention or heart failure.
• Renal papillary necrosis and another renal injury with long-term use. Use with caution in the elderly, those with impaired renal function, heart failure, liver dysfunction, and those taking diuretics, ACE-inhibitors, or angiotensin II antagonists. The use of this drug in patients with severe renal impairment is not recommended
• Serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), can be fatal and can occur without warning. Discontinue this drug at the first appearance of rash or skin reactions
• Serious and potentially fatal cardiovascular (CV) thrombotic events, myocardial infarction, and stroke. Patients with known CV disease/risk factors may be at greater risk

Storage Conditions Of Oximal 7.5 Mg Tablets

• Store below 25°c
• Don’t refrigerate
• Keep this medicine out of the sight and reach of children.
• Store in the original package to protect from moisture.
• Do not use this medicine after the expiry date which is stated on the box/blisters/label. The expiry date refers to the last day of the month.

For More Information About Meloxicam

• Ask your physician or pharmacist
• Visit Medscape at Information About Meloxicam
• Visit Drugbank at Information About Meloxicam
• Visit Drugs.com at Information About Meloxicam
• SFDA website